HPV-Vaccines / / edited by Gloria Calagna.
Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophyl...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | [Place of publication not identified] : : MDPI - Multidisciplinary Digital Publishing Institute,, 2023. |
Year of Publication: | 2023 |
Language: | English |
Physical Description: | 1 online resource (214 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993610551304498 |
---|---|
ctrlnum |
(CKB)5470000002907834 (NjHacI)995470000002907834 (EXLCZ)995470000002907834 |
collection |
bib_alma |
record_format |
marc |
spelling |
HPV-Vaccines / edited by Gloria Calagna. [Place of publication not identified] : MDPI - Multidisciplinary Digital Publishing Institute, 2023. 1 online resource (214 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophylactic HPV vaccines, surgery, radiotherapy, and chemotherapy, the disease burden remains heavy worldwide. Currently, three types of prophylactic vaccines-quadrivalent HPV vaccines, bivalent HPV vaccines, and a new nonavalent HPV vaccine-are commercially available. Although these vaccines protect against 90% of HPV infections, their capacity to eliminate pre-existing infections is limited. In this Topical Collection, we aim to systematically cover the progress, current status, and future prospects of various vaccines being developed for the prevention and treatment of HPV-associated lesions and cancers. Vaccines. Papillomaviruses. 3-0365-5918-3 Calagna, Gloria, editor. |
language |
English |
format |
eBook |
author2 |
Calagna, Gloria, |
author_facet |
Calagna, Gloria, |
author2_variant |
g c gc |
author2_role |
TeilnehmendeR |
title |
HPV-Vaccines / |
spellingShingle |
HPV-Vaccines / |
title_full |
HPV-Vaccines / edited by Gloria Calagna. |
title_fullStr |
HPV-Vaccines / edited by Gloria Calagna. |
title_full_unstemmed |
HPV-Vaccines / edited by Gloria Calagna. |
title_auth |
HPV-Vaccines / |
title_new |
HPV-Vaccines / |
title_sort |
hpv-vaccines / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2023 |
physical |
1 online resource (214 pages) |
isbn |
3-0365-5918-3 |
callnumber-first |
Q - Science |
callnumber-subject |
QR - Microbiology |
callnumber-label |
QR406 |
callnumber-sort |
QR 3406 H688 42023 |
illustrated |
Not Illustrated |
dewey-hundreds |
500 - Science |
dewey-tens |
570 - Life sciences; biology |
dewey-ones |
576 - Genetics & evolution |
dewey-full |
576.6484 |
dewey-sort |
3576.6484 |
dewey-raw |
576.6484 |
dewey-search |
576.6484 |
work_keys_str_mv |
AT calagnagloria hpvvaccines |
status_str |
n |
ids_txt_mv |
(CKB)5470000002907834 (NjHacI)995470000002907834 (EXLCZ)995470000002907834 |
carrierType_str_mv |
cr |
is_hierarchy_title |
HPV-Vaccines / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653284186914817 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01847nam a2200289 i 4500</leader><controlfield tag="001">993610551304498</controlfield><controlfield tag="005">20230816114832.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230816s2023 xx o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5470000002907834</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995470000002907834</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995470000002907834</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR406</subfield><subfield code="b">.H688 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">576.6484</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">HPV-Vaccines /</subfield><subfield code="c">edited by Gloria Calagna.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Place of publication not identified] :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (214 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophylactic HPV vaccines, surgery, radiotherapy, and chemotherapy, the disease burden remains heavy worldwide. Currently, three types of prophylactic vaccines-quadrivalent HPV vaccines, bivalent HPV vaccines, and a new nonavalent HPV vaccine-are commercially available. Although these vaccines protect against 90% of HPV infections, their capacity to eliminate pre-existing infections is limited. In this Topical Collection, we aim to systematically cover the progress, current status, and future prospects of various vaccines being developed for the prevention and treatment of HPV-associated lesions and cancers.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Vaccines.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Papillomaviruses.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-5918-3</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calagna, Gloria,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-18 03:30:30 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-07-04 13:45:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5346844360004498&Force_direct=true</subfield><subfield code="Z">5346844360004498</subfield><subfield code="b">Available</subfield><subfield code="8">5346844360004498</subfield></datafield></record></collection> |